Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Aneurysm I: Introduction

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...

Aneurysm III: Interprofessional Care

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Portal Hypertension

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic hepatitis C viral infection.

Scandinavian journal of clinical and laboratory investigation·2014

Same author

Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.

Antimicrobial agents and chemotherapy·2006

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 18, 2026

A Murine Model of Carotid Aneurysm Formation

A Murine Model of Carotid Aneurysm Formation

Published on: September 9, 2025

Wilson's disease in association with anetoderma.

Irina Ivanova Ivanova¹, Iskren Andreev Kotzev, Maria Vassileva Atanassova

¹Department of Internal Diseases, Clinic of Gastroenterology, University Hospital "St.Marina", 1 Hristo Smirnenski Str., Varna, 9010, Bulgaria, irinaiivanova@abv.bg.

Clinical Journal of Gastroenterology

|January 25, 2015

Summary

This summary is machine-generated.

This case study reports the first association between Wilson's disease, a copper metabolism disorder, and primary anetoderma, a rare skin condition. The patient

More Related Videos

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Published on: November 21, 2019

Related Experiment Videos

Last Updated: Apr 18, 2026

A Murine Model of Carotid Aneurysm Formation

A Murine Model of Carotid Aneurysm Formation

Published on: September 9, 2025

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm

Published on: August 1, 2025

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Published on: November 21, 2019

Area of Science:

Hepatology
Dermatology
Genetics

Background:

Wilson's disease is an inherited disorder affecting copper homeostasis, primarily impacting the liver and nervous system.
Anetoderma is a rare skin condition characterized by localized loss of elastic tissue in the dermis.
Previous literature suggests a potential link between anetoderma and D-Penicillamine treatment.

Observation:

A 26-year-old male presented with elevated liver enzymes, low ceruloplasmin, and increased urinary copper excretion, indicative of Wilson's disease.
The patient also exhibited numerous small, pale papules on his upper body, diagnosed as primary anetoderma.
Liver biopsy confirmed chronic hepatitis with significant fibrosis.

Findings:

Genetic analysis revealed a compound heterozygote genotype, confirming the diagnosis of Wilson's disease.
The co-occurrence of Wilson's disease and primary anetoderma was observed in this patient.
Treatment with D-Penicillamine (1500 mg/day) normalized liver enzymes within 12 months, while skin lesions remained stable.

Implications:

This case represents the first documented association between Wilson's disease and primary anetoderma.
The findings prompt further investigation into potential underlying mechanisms connecting copper metabolism disorders and dermatological conditions.
Understanding this association may inform future diagnostic and therapeutic approaches for patients with Wilson's disease.